Browse Category

NYSE:TOL News 9 December 2025 - 27 January 2026

Mortgage rates today near 6% as Fed meeting kicks off; housing stocks mixed

Mortgage rates today near 6% as Fed meeting kicks off; housing stocks mixed

U.S. 30-year mortgage rates hovered near 6.1% early Tuesday, with Bankrate showing an average of 6.20% and Mortgage News Daily at 6.17%. The 10-year Treasury yield closed at 4.22%. Homebuilder shares slipped, with Lennar down 1.1% and the iShares U.S. Home Construction ETF off 0.6%. Investors await the Federal Reserve’s policy meeting for signals on future borrowing costs.
Mortgage rates today hold near 3-year lows as Fed meeting nears; homebuilder shares slip

Mortgage rates today hold near 3-year lows as Fed meeting nears; homebuilder shares slip

The average 30-year fixed mortgage rate holds near 6%, its lowest level in over three years, with Freddie Mac reporting 6.09% and Bankrate at 6.20%. Core PCE inflation remains above the Fed’s 2% target at 2.8%. Treasury yields and new inflation data are shaping rates ahead of the Federal Reserve’s meeting next week. Mortgage applications jumped 14.1% last week, according to the Mortgage Bankers Association.
D.R. Horton stock rises as KBW trims target — what Wall Street is watching next

D.R. Horton stock rises as KBW trims target — what Wall Street is watching next

NEW YORK, Jan 12, 2026, 15:07 (ET) — Regular session D.R. Horton’s shares edged up roughly 1% to $158.82 Monday afternoon, even as Keefe Bruyette & Woods lowered its price target on the homebuilder. The firm cut the target to $168 from $175 but kept its market perform rating. (MarketScreener) This move is significant as the sector has been reacting to minor tweaks in rate forecasts and policy talk. Investors are hunting for clues that affordability is improving or that builders might reduce incentives without hurting sales. D.R. Horton faces a key test soon. Investors are gearing up ahead of
Toll Brothers Stock Slides After Q4 2025 Earnings Miss and Cautious 2026 Outlook: What It Means for TOL Investors

Toll Brothers Stock Slides After Q4 2025 Earnings Miss and Cautious 2026 Outlook: What It Means for TOL Investors

December 9, 2025 — New York Stock Exchange: TOL Toll Brothers, Inc. (NYSE: TOL), the largest U.S. builder of luxury homes, is under pressure today after reporting fiscal Q4 2025 results that combined a solid revenue performance with softer margins, weaker cash flow, and a cautious outlook for 2026. Shares are trading around $136 in early Tuesday action, down roughly 2% from Monday’s close of $138.94, as investors digest an earnings-per-share (EPS) miss and guidance that points to lower deliveries next fiscal year. Even after the pullback, the stock remains up around 8–10% year-to-date and not far from its 52‑week

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop